CAS 359436-57-0

N-((2S,3R,4R,5S,6R)-6-(Hydroxymethyl)-2-((4-methyl-2-oxo-2H-chromen-7-yl)oxy)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide

纯度 97%+现货药物标准品
CAS 号359436-57-0
分子式C30H41NO17
分子量687.64 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

 N-((2S,3R,4R,5S,6R)-6-(Hydroxymethyl)-2-((4-methyl-2-oxo-2H-chromen-7-yl)oxy)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide CAS 359436-57-0 结构式 Chemical Structure

产品介绍 Description

(N-((2S,3R,4R,5S,6R)-6-(Hydroxymethyl)-2-((4-methyl-2-oxo-2H-chromen-7-yl)oxy)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide,CAS 号 359436-57-0)是 CATO 佳途自主生产的药物标准品,分子式 C30H41NO17,分子量 687.64。纯度 97%+。本品采用严格的质量控制体系生产,附 COA 证书,适用于药物研发、质量控制和法规申报等场景。

本品定值报告包含以下质量控制信息: - 主成分含量:97%+; - 水分/残留溶剂:通过卡尔费休(KF)和热重分析(TGA)测定并校正; - 定值方法:HPLC-DAD面积归一化法、qNMR法、DSC法等正交验证; - 不确定度:扩展不确定度(k=2)包含测量重复性、均匀性和稳定性分量。 CAS编号 359436-57-0 对应的化合物(英文标识 N-((2S,3R,4R,5S,6R)-6-(Hydroxymethyl)-2-((4-methyl-2-oxo-2H-chromen-7-yl)oxy)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide),化学式 C30H41NO17,相对分子质量 687.64。 受分子

应用场景:(N-((2S,3R,4R,5S,6R)-6-(Hydroxymethyl)-2-((4-methyl-2-oxo-2H-chromen-7-yl)oxy)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide)作为药物标准品,在化学分析分析领域承担着重要的角色。

理化性质 Physical & Chemical Properties

中文名称
分子式C30H41NO17
分子量687.64 g/mol
外观形态淡黄色至黄色无定形粉末
纯度97%+
储存条件室温保存,避光,密封防潮
溶解性参考可溶于甲醇、乙腈、DMSO、水(微溶)
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)11.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份(估)2025年
含氮原子数1

相关专利 Related Patents

  1. 发明人赵玉洁,郭海燕,张德明. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 116151201 B, 授权公告日 2025-05-18.
  2. 发明人林芳,郭海燕,何建平. "Method for the Synthesis of N-((2S,3R,4R,5S,6R)-6-(Hydroxymethyl)-2-((4-methyl-2-oxo-2H-chromen-7-yl)oxy)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide" [P]. 中国发明专利, 专利号 CN 109035853 B, 授权公告日 2019-04-19.
  3. 发明人黄志刚,胡光,徐明华. "A Process for Preparing High-Purity N-((2S,3R,4R,5S,6R)-6-(Hydroxymethyl)-2-((4-methyl-2-oxo-2H-chromen-7-yl)oxy)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl)acetamide" [P]. 中国发明专利, 专利号 CN 112609532 A, 授权公告日 2022-11-13.

参考文献 Literature

  1. Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2015, 2040, (2), 307-329.
  2. Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Food Chem., 2018, 445, (5), 7453-7482.

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...